Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AVITA Medical (RCEL) Non Operating Income (2019 - 2025)

AVITA Medical's Non Operating Income history spans 6 years, with the latest figure at $20000.0 for Q4 2025.

  • For Q4 2025, Non Operating Income rose 104.18% year-over-year to $20000.0; the TTM value through Dec 2025 reached -$1.0 million, down 51800.0%, while the annual FY2025 figure was -$1.0 million, 103700.0% down from the prior year.
  • Non Operating Income reached $20000.0 in Q4 2025 per RCEL's latest filing, up from -$2.8 million in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $6.3 million in Q4 2023 to a low of -$2.8 million in Q3 2025.
  • Average Non Operating Income over 4 years is $532285.7, with a median of $13500.0 recorded in 2021.
  • The largest YoY upside for Non Operating Income was 104.18% in 2025 against a maximum downside of 1098.48% in 2025.
  • A 4-year view of Non Operating Income shows it stood at $2000.0 in 2021, then skyrocketed by 317000.0% to $6.3 million in 2023, then plummeted by 107.55% to -$479000.0 in 2024, then skyrocketed by 104.18% to $20000.0 in 2025.
  • Per Business Quant, the three most recent readings for RCEL's Non Operating Income are $20000.0 (Q4 2025), -$2.8 million (Q3 2025), and $2.5 million (Q2 2025).